Aline Dugravot

Aline Dugravot

Auto-generated profile, based on publicly available information

Aline Dugravot

INSERM, U1018, Centre for Research in Epidemiology and Population Health, Hôpital Paul Brousse, Villejuif, France

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 January 2012 in BMJ
Verified
Journal Article
Open access
PDF file
ASArchana Singh-Manoux
Archana Singh-Manoux
MKMika Kivimaki
Mika Kivimaki
MGM Maria Glymour
M Maria Glymour
AEAlexis Elbaz
Alexis Elbaz
CBClaudine Berr
Claudine Berr
ADAline Dugravot
Aline Dugravot
Objectives To estimate 10 year decline in cognitive function from longitudinal data in a middle aged cohort and to examine whether age cohorts can be compared with cross sectional data to infer the effect of age on cognitive decline. Design Prospective cohort study. At study inception in 1985-8, there were 10 308 participants, representing a recruitment rate of 73%. Setting Civil service departments in London, United Kingdom. Participants 5198 men and 2192 women, aged 45-70 at the beginning of cognitive testing in 1997-9. Main outcome measure Tests of memory, reasoning, vocabulary, and phonemic and semantic fluency, assessed three times over 10 years. Results All cognitive scores, except vocabulary, declined in all five age categories (age 45-49, 50-54, 55-59, 60-64, and 65-70 at baseline), with evidence of faster decline in older people. In men, the 10 year decline, shown as change/range of test×100, in reasoning was −3.6% (95% confidence interval −4.1% to −3.0%) in those aged 45-49 at baseline and −9.6% (−10.6% to −8.6%) in those aged 65-70. In women, the corresponding decline was −3.6% (−4.6% to −2.7%) and −7.4% (−9.1% to −5.7%). Comparisons of longitudinal and cross sectional effects of age suggest that the latter overestimate decline in women because of cohort differences in education. For example, in women aged 45-49 the longitudinal analysis showed reasoning to have declined by −3.6% (−4.5% to −2.8%) but the cross sectional effects suggested a decline of −11.4% (−14.0% to −8.9%). Conclusions Cognitive decline is already evident in middle age (age 45-49).

1 July 2017 in JAMA Psychiatry
Verified
Journal Article
Open access
PDF file
ASArchana Singh-Manoux
Archana Singh-Manoux
ADAline Dugravot
Aline Dugravot
AFAgnes Fournier
Agnes Fournier
JAJessica Abell
Jessica Abell
KEKlaus Ebmeier
Klaus Ebmeier
SSSéverine Sabia
Séverine Sabia
Alzheimer disease (AD), the most common form of dementia, is a progressive disorder. The histopathological hallmarks of AD begin decades prior to its clinical expression1,2; a recent study estimated that amyloid-β deposits form over a period of more than 2 decades.3 The long preclinical phase of dementia has implications for the timing of interventions. There is growing consensus that interventions should target the earliest possible phase, perhaps the asymptomatic stage,4,5 to be effective. The other major implication, which has received less attention to date, is the analytic framework used to identify putative risk factors for dementia. When measured in the years immediately prior to dementia diagnosis, these factors are likely to reflect common causes, the effects of preclinical disease (reverse causation), or prodromal changes rather than risk factors for dementia.

21 September 2017 in Alzheimer's & Dementia
Verified
Journal Article
Open access
ASArchana Singh‐Manoux
Archana Singh‐Manoux
ADAline Dugravot
Aline Dugravot
MSMartin Shipley
Martin Shipley
EBEric J. Brunner
Eric J. Brunner
AEAlexis Elbaz
Alexis Elbaz
MKMika Kivimaki
Mika Kivimaki
Introduction: We examined whether obesity at ages 50, 60, and 70 years is associated with subsequent dementia. Changes in body mass index (BMI) for more than 28 years before dementia diagnosis were compared with changes in BMI in those free of dementia.Methods: A total of 10,308 adults (33% women) aged 35 to 55 years in 1985 were followed up until 2015. BMI was assessed six times and 329 cases of dementia were recorded.Results: Obesity (BMI ≥30 kg/m2) at age 50 years (hazard ratio = 1.93; 1.35–2.75) but not at 60 or 70 years was associated with risk of dementia. Trajectories of BMI differed in those with dementia compared with all others (P < .0001) or to matched control subjects (P < .0001) such that BMI in dementia cases was higher from 28 years (P = .001) to 16 years (P = .05) and lower starting 8 years before diagnosis.Discussion: Obesity in midlife and weight loss in the preclinical phase characterizes dementia; the current obesity epidemic may affect future dementia rates.

22 June 2017 in BMJ
Verified
Journal Article
Open access
PDF file
SSSéverine Sabia
Séverine Sabia
ADAline Dugravot
Aline Dugravot
JDJean-François Dartigues
Jean-François Dartigues
JAJessica Abell
Jessica Abell
AEAlexis Elbaz
Alexis Elbaz
ASArchana Singh-Manoux
Archana Singh-Manoux
Objective To test the hypotheses that physical activity in midlife is not associated with a reduced risk of dementia and that the preclinical phase of dementia is characterised by a decline in physical activity. Design Prospective cohort study with a mean follow-up of 27 years. Setting Civil service departments in London (Whitehall II study). Participants 10 308 participants aged 35-55 years at study inception (1985-88). Exposures included time spent in mild, moderate to vigorous, and total physical activity assessed seven times between 1985 and 2013 and categorised as “recommended” if duration of moderate to vigorous physical activity was 2.5 hours/week or more. Main outcome measures A battery of cognitive tests was administered up to four times from 1997 to 2013, and incident dementia cases (n=329) were identified through linkage to hospital, mental health services, and mortality registers until 2015. Results Mixed effects models showed no association between physical activity and subsequent 15 year cognitive decline. Similarly, Cox regression showed no association between physical activity and risk of dementia over an average 27 year follow-up (hazard ratio in the “recommended” physical activity category 1.00, 95% confidence interval 0.80 to 1.24). For trajectories of hours/week of total, mild, and moderate to vigorous physical activity in people with dementia compared with those without dementia (all others), no differences were observed between 28 and 10 years before diagnosis of dementia. However, physical activity in people with dementia began to decline up to nine years before diagnosis (difference in moderate to vigorous physical activity −0.39 hours/week; P=0.05), and the difference became more pronounced (−1.03 hours/week; P=0.005) at diagnosis. Conclusion This study found no evidence of a neuroprotective effect of physical activity. Previous findings showing a lower risk of dementia in physically active people may be attributable to reverse causation—that is, due to a decline in physical activity levels in the preclinical phase of dementia.

1 March 2014 in European Heart Journal
Verified
Journal Article
Open access
PDF file
GHGuy-Marino Hinnouho
Guy-Marino Hinnouho
SCSébastien Czernichow
Sébastien Czernichow
ADAline Dugravot
Aline Dugravot
Hermann NabiHermann Nabi
Hermann Nabi
EBEric J. Brunner
Eric J. Brunner
ASArchana Singh-Manoux
Archana Singh-Manoux
The metabolically healthy obese (MHO) phenotype refers to obese individuals with a favourable metabolic profile. Its prognostic value is unclear and may depend on the health outcome being examined. We examined the association of MHO phenotype with incident cardiovascular disease (CVD) and type 2 diabetes. Body mass index and metabolic health, assessed using the Adult Treatment Panel-III (ATP-III) criteria, were assessed on 7122 participants (69.7% men) from the Whitehall II study, aged 39–63 years in 1991–93. Incident CVD (coronary heart disease or stroke) and type 2 diabetes were ascertained from medical screenings (every 5 years), hospital data, and registry linkage until 2009. A total of 657 individuals (9.2% of the cohort) were obese and 42.5% of these were classified as MHO in 1991–93. Over the median follow-up of 17.4 years, there were 828 incident cases of CVD and 798 incident cases of type 2 diabetes. Compared with metabolically healthy normal weight individuals, MHO subjects were at increased risk for CVD (HR = 1.97, 95% CI: 1.38–2.80) and type 2 diabetes (3.25, 95% CI: 2.32–4.54). There was excess risk in metabolically unhealthy obese compared with MHO for type 2 diabetes (1.98, 95% CI: 1.39–2.83) but not CVD (1.23, 95% CI: 0.81–1.87). Treating all measures as time varying covariates produced similar findings. For type 2 diabetes, the MHO phenotype is associated with lower risk than the metabolically unhealthy obese, but for CVD the risk is as elevated in both obesity phenotypes.

22 February 2011 in PLOS Medicine
Verified
Journal Article
Open access
PDF file
SSSilvia Stringhini
Silvia Stringhini
ADAline Dugravot
Aline Dugravot
MSMartin Shipley
Martin Shipley
MGMarcel Goldberg
Marcel Goldberg
MZMarie Zins
Marie Zins
ASArchana Singh-Manoux
Archana Singh-Manoux
Differences in morbidity and mortality between socioeconomic groups constitute one of the most consistent findings of epidemiologic research. However, research on social inequalities in health has yet to provide a comprehensive understanding of the mechanisms underlying this association. In recent analysis, we showed health behaviours, assessed longitudinally over the follow-up, to explain a major proportion of the association of socioeconomic status (SES) with mortality in the British Whitehall II study. However, whether health behaviours are equally important mediators of the SES-mortality association in different cultural settings remains unknown. In the present paper, we examine this issue in Whitehall II and another prospective European cohort, the French GAZEL study. We included 9,771 participants from the Whitehall II study and 17,760 from the GAZEL study. Over the follow-up (mean 19.5 y in Whitehall II and 16.5 y in GAZEL), health behaviours (smoking, alcohol consumption, diet, and physical activity), were assessed longitudinally. Occupation (in the main analysis), education, and income (supplementary analysis) were the markers of SES. The socioeconomic gradient in smoking was greater (p<0.001) in Whitehall II (odds ratio [OR] = 3.68, 95% confidence interval [CI] 3.11–4.36) than in GAZEL (OR = 1.33, 95% CI 1.18–1.49); this was also true for unhealthy diet (OR = 7.42, 95% CI 5.19–10.60 in Whitehall II and OR = 1.31, 95% CI 1.15–1.49 in GAZEL, p<0.001). Socioeconomic differences in mortality were similar in the two cohorts, a hazard ratio of 1.62 (95% CI 1.28–2.05) in Whitehall II and 1.94 in GAZEL (95% CI 1.58–2.39) for lowest versus highest occupational position. Health behaviours attenuated the association of SES with mortality by 75% (95% CI 44%–149%) in Whitehall II but only by 19% (95% CI 13%–29%) in GAZEL. Analysis using education and income yielded similar results. Health behaviours were strong predictors of mortality in both cohorts but their association with SES was remarkably different. Thus, health behaviours are likely to be major contributors of socioeconomic differences in health only in contexts with a marked social characterisation of health behaviours. Please see later in the article for the Editors' Summary